Sunshine Biopharma (SBFMW) Net Income Growth (1y) (2012 - 2026)
Sunshine Biopharma (SBFMW) Net Income Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 68.18% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -0.17% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.68% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,405.06% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -615.22% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -14.93% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 62.34% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 237.83% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -5.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.43% |
| Dec 31, 2025 | -149.42% |
| Sep 30, 2025 | 26.21% |
| Jun 30, 2025 | -258.25% |
| Mar 31, 2025 | 8.10% |
| Dec 31, 2024 | 446.59% |
| Sep 30, 2024 | -83.86% |
| Jun 30, 2024 | 45.21% |
| Mar 31, 2024 | 24.59% |
| Dec 31, 2023 | 94.68% |
| Sep 30, 2023 | 55.29% |
| Jun 30, 2023 | -67.41% |
| Mar 31, 2023 | -37.71% |
| Dec 31, 2022 | -3,624.47% |
| Sep 30, 2022 | 63.93% |
| Jun 30, 2022 | 81.28% |
| Mar 31, 2022 | 80.01% |
| Sep 30, 2019 | -140.02% |
| Jun 30, 2019 | -139.02% |
| Mar 31, 2019 | 99.13% |